Penn Vet | Clinical Trial Detail - New oral combination treatment for insulin-treated diabetic dogs
Contact
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
610-444-5800
Directions
Ryan Hospital Philadelphia, PA
Emergencies:
215-746-8911
Appointments:
215-746-8387
Directions

New oral combination treatment for insulin-treated diabetic dogs

Feb 21, 2022

Description: Dogs with diabetes have a high concentration of glucose in the blood, and the goal of treatment is to decrease this high concentration of blood glucose. We are conducting a clinical trial with an oral medication that is used, in combination with insulin, for treatment of diabetes in humans, and has been given safely to dogs. The medication decreases blood glucose by increasing its secretion in the urine. This could help improve the glucose regulation in insulin-treated dogs with diabetes.

Requirements:

  • For this free to the owner study, dogs with diabetes will be required to visit the hospital twice over a 10-day period and will have a free FreeStyle Libre glucose monitor placed.
  • Owners will have to scan the glucose monitor every 8 hours at home and administer the oral medication once a day for 7 days.

Contact: For more information about participating in the study please email us at jbox@upenn.edu or rhess@upenn.edu


Institutional approval: POAP #624 IACUC #807034